I'm not too concerned about vultures. Management have deliberately separated the business into 2 segments:
1. Glaucoma (iTrack)
2. AMD (AlphaRet) - from memory this is a complete separate entity which they created a couple of years ago
The 2RT partnership is for AlphaRet only.
iTrack, we know comparable transactions in this space, so management cannot accept anything not close to the comparables.
Nova Eye Medical (EYE) Discussion, page-689
Add EYE (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
22.0¢ |
Change
0.010(4.76%) |
Mkt cap ! $50.39M | |||
| Open | High | Low | Value | Volume |
| 21.5¢ | 22.5¢ | 21.0¢ | $84.60K | 389.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 100224 | 22.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 23.5¢ | 23847 | 1 |
View Market Depth
| Last trade - 16.10pm 09/08/2024 (20 minute delay) ? |
| EYE (ASX) Chart |